S no. | Age (years) | Prior intervention | Presenting BCVA | Our intervention | Organism | Sensitivity | Final BCVA |
---|---|---|---|---|---|---|---|
1 | 70 | IOAB | LP | PPV + 2x IOAB | P. aeroginosa | Sensitive to amikacin, ceftazidime, gatifloxacin, moxifloxacin, cirprofloxacin, and ofloxacin Resistant to chloramphenicol | LP |
2 | 10 | 2x IOAB | LP | PPV + 2x IOAB | Streptococcus pyogenes | Sensitive to vanomycin, gatifloxacin, moxifloxacin, cirprofloxacin, and ofloxacin Resistant to amikacin | |
3 | 64 | AC wash + IOAB | LP | Vitreous biopsy + 5x IOAB | P. aeruginosa | Sensitive to amikacin, ceftazidime, gatifloxacin, moxifloxacin, cirprofloxacin, and ofloxacin Resistant to tobramycin | LP |
4 | 62 | Vitreous biosy + IOAB | 6/36 | PPV + 2x IOAB | R. radiobacter | Sensitive to amikacin, ceftazidime, gatifloxacin, moxifloxacin, cirprofloxacin, ofloxacin Resistant to chloramphenicol | 6/36 |
5 | 55 | 2x IOAB | 6/36 | PPV + IOAB + 2x Intravitreal Amphoterecin B | C. pelliculosa | — | 6/15 |